Domov › Stanja po COVID-19 (dolgotrajni COVID) › Missouri
Klinične študije za Stanja po COVID-19 (dolgotrajni COVID) v Missouri
4 študij za Stanja po COVID-19 (dolgotrajni COVID) išče udeležence na lokacijah v Missouri.
Mesta v Missouri
Uradno besedilo študije (angleško)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- Saint Louis University Center for Vaccine Development, St Louis
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Kansas City
- Research Site, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05624450Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
- Washington University in Saint Louis Department of Emergency Medicine, Emergency Care Research Core, St Louis
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–60 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT06848309EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- St. Louis Children's Hospital, St Louis
- Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 3
Starost 0–17 · Vsi spoli · Posodobljeno 17. jul. 2025 · NCT05261139Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.